September 28, 2020

The Niche

Knoepfler lab stem cell blog

Miller School’s Interdisciplinary Stem Cell Institute (ISCI)

3 min read

A team at the University of Miami has launched a claimed first of its kind stem cell clinic trial for Alzheimer’s Disease (AD). The trial seems somewhat unique in using mesenchymal stem cells (MSC) for AD and is being run with biotech Longeveron. You can read more on the actual clinic trial including all the pertinent details here. I was unable to find a website for the company, but it is described here. Another stem cell trial for AD was announced last year that drew …Read More